| abstract |
The present disclosure teaches methods for treating airway diseases that include amelioration of symptoms of airway inflammation, airway remodeling, and airway hyperresponsiveness. The method comprises administering an anti-fibrotic agent with amniotic epithelial cells or their functional equivalents or exosomes. |